开拓创新·关爱人生
万邦德制药集团—专业从事现代中药、化学原料药及其制剂研发、生产和销售的高新技术企业
投资者关系
2022
2022-08-29
In February, Phloroglucinol injection passed the consistency evaluation (the first in China)
2021
2022-08-29
In May, the R&D building was completed and put into use
In October, a postdoctoral workstation was established
2020
2022-08-29
In January, the name was changed to Wanbangde Pharmaceutical Group Co., Ltd.
In February, Wanbangde was successfully restructured and listed (stock code 002082), and the pharmaceutical group entered the listed company system
2019
2022-08-29
In March, Wanbangde Pharmaceutical Group officially became a wholly-owned subsidiary of Wanbangde Pharmaceutical Holding Group Co., Ltd.
2018
2022-08-29
In June, the anti-Alzheimer's drug Huperzine A controlled-release tablet was approved for clinical trials
In December, the academician expert workstation led by Academician Tang Xican was rated as "National Academician Workstation"
2017
2022-08-29
In April, the first domestic collaborative innovation alliance of medical research enterprises for pharmaceutical products was established - Ginkgo Leaf Dropping Pill Medical Research Enterprise Collaborative Innovation Alliance
Previous page
1
2
3
Next page
Copyright 2016 © wanbang.com.cn All Rights Reserved.
Internet drug information service qualification certificate :(zhejiang) - non-operating -2023-0143 Powered by 300.cn
